The DOI matches its Crossref record; 332 of the 332 references it cites were found in a registry or an index.
Animal models of Duchenne muscular dystrophy: from basic mechanisms to gene therapy
Open accessAbstract
Duchenne muscular dystrophy (DMD) is a progressive muscle-wasting disorder. It is caused by loss-of-function mutations in the dystrophin gene. Currently, there is no cure. A highly promising therapeutic strategy is to replace or repair the defective dystrophin gene by gene therapy. Numerous animal models of DMD have been developed over the last 30 years, ranging from invertebrate to large mammalian models. mdx mice are the most commonly employed models in DMD research and have been used to lay the groundwork for DMD gene therapy. After ~30 years of development, the field has reached the stage at which the results in mdx mice can be validated and scaled-up in symptomatic large animals. The canine DMD (cDMD) model will be excellent for these studies. In this article, we review the animal models for DMD, the pros and cons of each model system, and the history and progress of preclinical DMD gene therapy research in the animal models. We also discuss the current and emerging challenges in this field and ways to address these challenges using animal models, in particular cDMD dogs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–332 of 332
Gene and cell‐mediated therapies for muscular dystrophy
Konieczny, P., Swiderski, K., & Chamberlain, J. S. (2012) · Muscle & Nerve · doi:10.1002/mus.23738 · Cited by 95
The Polyproline Site in Hinge 2 Influences the Functional Capacity of Truncated Dystrophins
Banks, G. B., Judge, L. M., Allen, J. M., & Chamberlain, J. S. (2010) · PLoS Genetics · doi:10.1371/journal.pgen.1000958 · Cited by 94
Ohshima, S., Shin, J., Yuasa, K., Nishiyama, A., Kira, J., Okada, T., & Takeda, S. (2008) · Molecular Therapy · doi:10.1038/mt.2008.225 · Cited by 94
Bish, L. T., Sleeper, M. M., Forbes, S. C., Wang, B., Reynolds, C., Singletary, G. E., Trafny, D. J., Morine, K., Sanmiguel, J. C., Cecchini, S., et al. (2011) · Molecular Therapy · doi:10.1038/mt.2011.264 · Cited by 94
Wakefield, P. M., Tinsley, J. M., Wood, M. J. A., Gilbert, R., Karpati, G., & Davies, K. E. (2000) · Gene Therapy · doi:10.1038/sj.gt.3301066 · Cited by 94
Lai, Y., Zhao, J., Yue, Y., & Duan, D. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1211431109 · Cited by 93
Self-citationSmith, B. F., Yue, Y., Woods, P. R., Kornegay, J. N., Shin, J., Williams, R. R., & Duan, D. (2010) · Laboratory Investigation · doi:10.1038/labinvest.2010.146 · Cited by 92
Self-citationNakamura, A., Yoshida, K., Fukushima, K., Ueda, H., Urasawa, N., Koyama, J., Yazaki, Y., Yazaki, M., Sakai, T., Haruta, S., et al. (2008) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2006.12.012 · Cited by 92
Valentine, B. A., Cooper, B. J., Cummings, J. F., & deLahunta, A. (1986) · Acta Neuropathologica · doi:10.1007/bf00688053 · Cited by 92
Duchenne's cardiomyopathy in a canine model: electrocardiographic and echocardiographic studies
Moise, N. S., Valentine, B. A., Brown, C. A., Erb, H. N., Beck, K. A., Cooper, B. J., & Gilmour, R. F. (1991) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(10)80202-5 · Cited by 89
Loss of Dp140 regulatory sequences is associated with cognitive impairment in dystrophinopathies
Bardoni, A., Felisari, G., Sironi, M., Comi, G. P., Lai, M., Robotti, M., & Bresolin, N. (2000) · Neuromuscular Disorders · doi:10.1016/s0960-8966(99)00108-x · Cited by 89
Warner, L. E., DelloRusso, C., Crawford, R. W., Rybakova, I. N., Patel, J. R., Ervasti, J. M., & Chamberlain, J. S. (2002) · Human Molecular Genetics · doi:10.1093/hmg/11.9.1095 · Cited by 89
Development of Duchenne-type cardiomyopathy. Morphologic studies in a canine model.
Valentine, B. A., Cummings, J. F., & Cooper, B. J. (1989) · Europe PMC (PubMed Central) · Cited by 88
Duchenne Muscular Dystrophy Gene Therapy in the Canine Model
Duan, D. (2015) · Human Gene Therapy Clinical Development · doi:10.1089/humc.2015.006 · Cited by 88
Self-citationBulman, D. E., Murphy, E. G., Zubrzycka‐Gaarn, E. E., Worton, R. G., & Ray, P. N. (1991) · Europe PMC (PubMed Central) · Cited by 87
Deletion of the dystrophin muscle promoter in feline muscular dystrophy
Winand, N. J., Edwards, M. M., Pradhan, D., Berian, C. A., & Cooper, B. J. (1994) · Neuromuscular Disorders · doi:10.1016/0960-8966(94)90082-5 · Cited by 85
AAV-microdystrophin Therapy Improves Cardiac Performance in Aged Female mdx Mice
Bostick, B., Shin, J.-H., Yue, Y., & Duan, D. (2011) · Molecular Therapy · doi:10.1038/mt.2011.154 · Cited by 85
Self-citationMuscular dystrophy: new challenges and review of the current clinical trials
Mercuri, E. M., & Muntoni, F. (2013) · Current Opinion in Pediatrics · doi:10.1097/mop.0b013e328365ace5 · Cited by 85
Challenges and opportunities in dystrophin-deficient cardiomyopathy gene therapy
Duan, D. (2006) · Human Molecular Genetics · doi:10.1093/hmg/ddl180 · Cited by 85
Self-citationHowell, J. M., Lochmüller, H., O’Hara, A. J., Fletcher, S., Kakulas, B. A., Massie, B., Nalbantoglu, J. N., & Karpati, G. (1998) · Human Gene Therapy · doi:10.1089/hum.1998.9.5-629 · Cited by 84
Muscle and joint elastic properties during elbow flexion in Duchenne muscular dystrophy
Cornu, C., Goubel, F., & Fardeau, M. (2001) · The Journal of Physiology · doi:10.1111/j.1469-7793.2001.0605a.x · Cited by 81
Meganucleases can restore the reading frame of a mutated dystrophin
Chapdelaine, P., Pichavant, C., Rousseau, J., Pâques, F., & Tremblay, J. P. (2010) · Gene Therapy · doi:10.1038/gt.2010.26 · Cited by 81
Miranda, R., Sebrié, C., Degrouard, J., Gillet, B., Jaillard, D., Laroche, S., & Vaillend, C. (2008) · Cerebral Cortex · doi:10.1093/cercor/bhn135 · Cited by 80
Shimatsu, Y., Yoshimura, M., Yuasa, K., Urasawa, N., Tomohiro, M., Nakura, M., Tanigawa, M., Nakamura, A., & Takeda, S. (2005) · PubMed · Cited by 79
Treatment of dystrophin cardiomyopathies
Finsterer, J., & Cripe, L. H. (2014) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2013.213 · Cited by 79
Full-Length Dystrophin Reconstitution with Adeno-Associated Viral Vectors
Lostal, W., Kodippili, K., Yue, Y., & Duan, D. (2014) · Human Gene Therapy · doi:10.1089/hum.2013.210 · Cited by 77
Self-citationDNA Damage, Somatic Aneuploidy, and Malignant Sarcoma Susceptibility in Muscular Dystrophies
Schmidt, W. M., Uddin, M. H., Dysek, S., Moser-Thier, K., Pirker, C., Höger, H., Ambros, I. M., Ambros, P. F., Berger, W., & Bittner, R. E. (2011) · PLoS Genetics · doi:10.1371/journal.pgen.1002042 · Cited by 77
Zebrafish models flex their muscles to shed light on muscular dystrophies
Berger, J., & Currie, P. D. (2012) · Disease Models & Mechanisms · doi:10.1242/dmm.010082 · Cited by 77
Dystrophin deficiency exacerbates skeletal muscle pathology in dysferlin-null mice
Han, R., Rader, E. P., Levy, J. R., Bansal, D., & Campbell, K. P. (2011) · Skeletal Muscle · doi:10.1186/2044-5040-1-35 · Cited by 77
Calcium Misregulation and the Pathogenesis of Muscular Dystrophy
Hopf, F. W., Turner, P. R., & Steinhardt, R. A. (2007) · Springer eBooks · doi:10.1007/978-1-4020-6191-2_16 · Cited by 75
Long‐term functional adeno‐associated virus‐microdystrophin expression in the dystrophic CXMDj dog
Koo, T., Okada, T., Athanasopoulos, T., Foster, H., Takeda, S., & Dickson, G. (2011) · The Journal of Gene Medicine · doi:10.1002/jgm.1602 · Cited by 74
Hakim, C. H., Grange, R. W., & Duan, D. (2011) · Journal of Applied Physiology · doi:10.1152/japplphysiol.01425.2010 · Cited by 74
Self-citationBostick, B., Shin, J., Yue, Y., Wasala, N. B., Lai, Y., & Duan, D. (2012) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2012.05.002 · Cited by 74
Self-citationvan Putten, M., Kumar, D., Hulsker, M., Hoogaars, W. M. H., Plomp, J. J., van Opstal, A. M., van Iterson, M., Admiraal, P. J. J., van Ommen, G. B., Hoen, P. A. C. ’., et al. (2012) · Neuromuscular Disorders · doi:10.1016/j.nmd.2011.10.011 · Cited by 74
Hoffman, E. P., & Gorospe, J. R. M. (1991) · Current topics in membranes · doi:10.1016/s0070-2161(08)60785-6 · Cited by 73
Sub-physiological sarcoglycan expression contributes to compensatory muscle protection in mdx mice
Li, D., Long, C., Yue, Y., & Duan, D. (2009) · Human Molecular Genetics · doi:10.1093/hmg/ddp015 · Cited by 73
Self-citationVaillend, C., Billard, J., Claudepierre, T., Rendón, Á., Dutar, P., & Ungerer, A. (1998) · Neuroscience · doi:10.1016/s0306-4522(98)00023-2 · Cited by 72
Li, D., Yue, Y., & Duan, D. (2008) · American Journal Of Pathology · doi:10.2353/ajpath.2008.071042 · Cited by 72
Self-citationZhang, Y., Yue, Y., Li, L., Hakim, C. H., Zhang, K., Thomas, G. D., & Duan, D. (2013) · Human Molecular Genetics · doi:10.1093/hmg/ddt224 · Cited by 71
Self-citationKoo, T., Malerba, A., Athanasopoulos, T., Trollet, C., Boldrin, L., Ferry, A., Popplewell, L. J., Foster, H., Foster, K., & Dickson, G. (2011) · Human Gene Therapy · doi:10.1089/hum.2011.020 · Cited by 71
Akkaraju, G. R., Huard, J., Hoffman, E. P., Goins, W. F., Pruchnic, R., Watkins, S. C., Cohen, J. B., & Glorioso, J. C. (1999) · The Journal of Gene Medicine · Cited by 71
mdx Mice Manifest More Severe Muscle Dysfunction and Diaphragm Force Deficits than Do mdx Mice
Beastrom, N., Lu, H., Macke, A., Canan, B. D., Johnson, E. K., Penton, C. M., Kaspar, B. K., Rodino‐Klapac, L. R., Zhou, L., Janssen, P. M. L., et al. (2011) · American Journal Of Pathology · doi:10.1016/j.ajpath.2011.07.009 · Cited by 71
Diaphragm rescue alone prevents heart dysfunction in dystrophic mice
Crisp, A., Yin, H., Goyenvalle, A., Betts, C., Moulton, H. M., Seow, Y., Babbs, A., Merritt, T. M., Saleh, A. F. A., Gait, M. J., et al. (2010) · Human Molecular Genetics · doi:10.1093/hmg/ddq477 · Cited by 70
Left Ventricular Dysfunction in Duchenne Muscular Dystrophy and Genotype
Ashwath, M. L., Jacobs, I. B., Crowe, C. A., Ashwath, R. C., Super, D. M., & Bahler, R. C. (2014) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2014.04.038 · Cited by 69
Wu, B., Xiao, B., Cloer, C., Shaban, M., Sali, A., Lu, P., Li, J., Nagaraju, K., Xiao, X., & Lu, Q. L. (2010) · Molecular Therapy · doi:10.1038/mt.2010.288 · Cited by 68
Yugeta, N., Urasawa, N., Fujii, Y., Yoshimura, M., Yuasa, K., Wada, M. R., Nakura, M., Shimatsu, Y., Tomohiro, M., Takahashi, A., et al. (2006) · BMC Cardiovascular Disorders · doi:10.1186/1471-2261-6-47 · Cited by 67
Ebihara, S., Guibinga, G.-H., Gilbert, R., Nalbantoglu, J. N., Massie, B., Karpati, G., & Petrof, B. J. (2000) · Physiological Genomics · doi:10.1152/physiolgenomics.2000.3.3.133 · Cited by 67
Yu, Y. (2004) · Human Molecular Genetics · doi:10.1093/hmg/ddh174 · Cited by 67
Kunkel, L. M. (2005) · The American Journal of Human Genetics · doi:10.1086/428143 · Cited by 66
Cozzi, F., Cerletti, M., Luvoni, G. C., Lombardo, R., Brambilla, P., Faverzani, S., Blàsevich, F., Cornelio, F., Pozza, O., & Mora, M. (2001) · Acta Neuropathologica · doi:10.1007/s004010000308 · Cited by 65
Canine X-linked muscular dystrophy: Selective involvement of muscles in neonatal dogs
Valentine, B. A., & Cooper, B. J. (1991) · Neuromuscular Disorders · doi:10.1016/0960-8966(91)90040-y · Cited by 65
Behavioral characterization of mdx3cv mice deficient in C-terminal dystrophins
Vaillend, C., & Ungerer, A. (1999) · Neuromuscular Disorders · doi:10.1016/s0960-8966(99)00029-2 · Cited by 65
Poussin, C., Mathis, C., Alexopoulos, L. G., Messinis, D. E., Dulize, R., Belcastro, V., Melas, I. N., Sakellaropoulos, T., Rhrissorrakrai, K., Bilal, E., et al. (2014) · Scientific Data · doi:10.1038/sdata.2014.9 · Cited by 63
Monitoring Murine Skeletal Muscle Function for Muscle Gene Therapy
Hakim, C. H., Li, D., & Duan, D. (2010) · Methods in molecular biology · doi:10.1007/978-1-61737-982-6_5 · Cited by 62
Self-citationVaillend, C., Perronnet, C., Ros, C., Gruszczynski, C., Goyenvalle, A., Laroche, S., Danos, O., García, L., & Peltékian, E. (2010) · Molecular Therapy · doi:10.1038/mt.2010.134 · Cited by 62
Gender influences cardiac function in the mdx model of duchenne cardiomyopathy
Bostick, B., Yue, Y., & Duan, D. (2010) · Muscle & Nerve · doi:10.1002/mus.21763 · Cited by 62
Self-citationDuchenne muscular dystrophy gene therapy: Lost in translation?
Duan, D. (2011) · Research and Reports in Biology · doi:10.2147/rrb.s13463 · Cited by 61
Self-citationGarcía-Pelagio, K. P., Bloch, R. J., Ortega, A., & Gonzalez-Serratos, H. (2011) · Journal of Muscle Research and Cell Motility · doi:10.1007/s10974-011-9238-9 · Cited by 60
Improvement of cardiac fibrosis in dystrophic mice by rAAV9-mediated microdystrophin transduction
Shin, J.-H., Nitahara‐Kasahara, Y., Hayashita‐Kinoh, H., Ohshima-Hosoyama, S., Kinoshita, K., Chiyo, T., Okada, H., Okada, T., & Takeda, S. (2011) · Gene Therapy · doi:10.1038/gt.2011.36 · Cited by 59
Fan, Z., Wang, J., Ahn, M., Shiloh‐Malawsky, Y., Chahin, N., Elmore, S., Bagnell, C. R., Wilber, K. P., An, H., Lin, W., et al. (2013) · Neuromuscular Disorders · doi:10.1016/j.nmd.2013.10.005 · Cited by 58
Stinckens, A., Georges, M., & Buys, N. (2010) · Animal Genetics · doi:10.1111/j.1365-2052.2010.02144.x · Cited by 58
Flanigan, K. M., Dunn, D. M., von Niederhausern, A. C., Howard, M. T., Mendell, J. R., Connolly, A. M., Saunders, C., Modrcin, A. C., Dasouki, M., Comi, G. P., et al. (2009) · Neuromuscular Disorders · doi:10.1016/j.nmd.2009.08.010 · Cited by 57
Li, D., Yue, Y., & Duan, D. (2010) · PLoS ONE · doi:10.1371/journal.pone.0015286 · Cited by 56
Self-citationFunctional significance of dystrophin positive fibres in Duchenne muscular dystrophy.
Nicholson, L. V. B., Johnson, M. A., Bushby, K. M. D., & Gardner‐Medwin, D. (1993) · Archives of Disease in Childhood · doi:10.1136/adc.68.5.632 · Cited by 56
Zucconi, E., Valadares, M. C., Vieira, N. M., Júnior, C. R. B., Secco, M., Jazedje, T., da Silva, H. C. A., Vainzof, M., & Zatz, M. (2009) · Neuromuscular Disorders · doi:10.1016/j.nmd.2009.10.011 · Cited by 55
Nitahara‐Kasahara, Y., Hayashita‐Kinoh, H., Chiyo, T., Nishiyama, A., Okada, H., Takeda, S., & Okada, T. (2013) · Human Molecular Genetics · doi:10.1093/hmg/ddu113 · Cited by 55
Miranda, R., Nudel, U., Laroche, S., & Vaillend, C. (2011) · Neurobiology of Disease · doi:10.1016/j.nbd.2011.02.017 · Cited by 54
Aartsma-Rus, A. M. (2012) · Methods in molecular biology · doi:10.1007/978-1-61779-767-5_7 · Cited by 54
Mosaic expression of dystrophin in carriers of canine X-linked muscular dystrophy.
Cooper, B. J., Gallagher, E. A., Smith, C. A., Valentine, B. A., & Winand, N. J. (1990) · PubMed · Cited by 52
Endonucleases: tools to correct the dystrophin gene
Rousseau, J., Chapdelaine, P., Boisvert, S., de Almeida, L. P., Corbeil, J., Montpetit, A., & Tremblay, J. P. (2011) · The Journal of Gene Medicine · doi:10.1002/jgm.1611 · Cited by 51
SERCA2a gene transfer improves electrocardiographic performance in aged mdx mice
Shin, J., Bostick, B., Yue, Y., Hajjar, R. J., & Duan, D. (2011) · Journal of Translational Medicine · doi:10.1186/1479-5876-9-132 · Cited by 50
Self-citationFine, D. M., Shin, J., Yue, Y., Volkmann, D. H., Leach, S. B., Smith, B. F., McIntosh, M., & Duan, D. (2011) · Neuromuscular Disorders · doi:10.1016/j.nmd.2011.03.010 · Cited by 49
Self-citationXu, R., Camboni, M., & Martin, P. T. (2007) · Neuromuscular Disorders · doi:10.1016/j.nmd.2006.12.004 · Cited by 49
Shin, J., Yue, Y., Srivastava, A., Smith, B. F., Lai, Y., & Duan, D. (2011) · Human Gene Therapy · doi:10.1089/hum.2011.147 · Cited by 48
Self-citationSchinkel, S., Bauer, R., Bekeredjian, R., Stucka, R., Rutschow, D., Lochmüller, H., Kleinschmidt, J. A., Katus, H. A., & Müller, O. J. (2012) · Human Gene Therapy · doi:10.1089/hum.2011.017 · Cited by 45
Vaillend, C., Ungerer, A., & Billard, J. (1999) · Synapse · doi:10.1002/(sici)1098-2396(199907)33:1<59::aid-syn6>3.0.co;2-k · Cited by 45
Canine Muscular Dystrophy: Confirmation of X-Linked Inheritance
Cooper, B. J., Valentine, B. A., Wilson, S., Patterson, D. F., & Concannon, P. W. (1988) · Journal of Heredity · doi:10.1093/oxfordjournals.jhered.a110543 · Cited by 45
Dallérac, G. M., Perronnet, C., Chagneau, C., Leblanc-Veyrac, P., Samson-Desvignes, N., Peltékian, E., Danos, O., García, L., Laroche, S., Billard, J., et al. (2011) · Neurobiology of Disease · doi:10.1016/j.nbd.2011.05.012 · Cited by 44
Muscle Structure Influences Utrophin Expression in mdx Mice
Banks, G. B., Combs, A. C., Odom, G. L., Bloch, R. J., & Chamberlain, J. S. (2014) · PLoS Genetics · doi:10.1371/journal.pgen.1004431 · Cited by 44
Dystrophin and dysferlin double mutant mice: a novel model for rhabdomyosarcoma
Hosur, V., Kavirayani, A. M., Riefler, J., Carney, L., Lyons, B. L., Gott, B., Cox, G. A., & Shultz, L. D. (2012) · Cancer Genetics · doi:10.1016/j.cancergen.2012.03.005 · Cited by 43
Heller, K. N., Montgomery, C. L., Janssen, P. M. L., Clark, K. R., Mendell, J. R., & Rodino‐Klapac, L. R. (2013) · Molecular Therapy · doi:10.1038/mt.2012.281 · Cited by 43
Gender differences in contractile and passive properties of mdx extensor digitorum longus muscle
Hakim, C. H., & Duan, D. (2011) · Muscle & Nerve · doi:10.1002/mus.22275 · Cited by 43
Self-citationGene therapy for Duchenne muscular dystrophy
Verhaart, I. E. C., & Aartsma-Rus, A. M. (2012) · Current Opinion in Neurology · doi:10.1097/wco.0b013e328357b0be · Cited by 42
Judge, L. M., Arnett, A. L. H., Banks, G. B., & Chamberlain, J. S. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddr433 · Cited by 42
Wasala, N. B., Bostick, B., Yue, Y., & Duan, D. (2013) · Human Molecular Genetics · doi:10.1093/hmg/ddt112 · Cited by 40
Self-citationDiagnosis and cell-based therapy for Duchenne muscular dystrophy in humans, mice, and zebrafish
Kunkel, L. M., Bachrach, E., Bennett, R. R., et al. (2006) · Journal of Human Genetics · doi:10.1007/s10038-006-0374-9 · Cited by 39
Deol, J. R., Danialou, G., Larochelle, N., Bourget, M., Moon, J.-S., Liu, A., Gilbert, R., Petrof, B. J., Nalbantoglu, J. N., & Karpati, G. (2007) · Molecular Therapy · doi:10.1038/sj.mt.6300260 · Cited by 38
Muscular dystrophy: The worm turns to genetic disease
Chamberlain, J. S., & Benian, G. M. (2000) · Current Biology · doi:10.1016/s0960-9822(00)00768-5 · Cited by 38
Hollinger, K., Yang, C. X., Montz, R. E., Nonneman, D., Ross, J. W., & Selsby, J. T. (2013) · The FASEB Journal · doi:10.1096/fj.13-241141 · Cited by 37
Exon-Skipping Therapy: A Roadblock, Detour, or Bump in the Road?
Hoffman, E. P., & McNally, E. M. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3008873 · Cited by 37
Partial restoration of cardiac function with PDZ nNOS in aged mdx model of Duchenne cardiomyopathy
Lai, Y., Zhao, J., Yue, Y., Wasala, N. B., & Duan, D. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddu029 · Cited by 36
Self-citationYang, H. T., Shin, J., Hakim, C. H., Pan, X., Terjung, R. L., & Duan, D. (2012) · PLoS ONE · doi:10.1371/journal.pone.0044438 · Cited by 35
Self-citationProgress in gene therapy of dystrophic heart disease
Lai, Y., & Duan, D. (2012) · Gene Therapy · doi:10.1038/gt.2012.10 · Cited by 35
Self-citationMilder course in Duchenne patients with nonsense mutations and no muscle dystrophin
Zatz, M., Pavanello, R. C. M., Lazar, M., et al. (2014) · Neuromuscular Disorders · doi:10.1016/j.nmd.2014.06.003 · Cited by 35
Lanfossi, M., Cozzi, F., Bugini, D., Colombo, S., Scarpa, P., Morandi, L. O., Galbiati, S., Cornelio, F., Pozza, O., & Mora, M. (1999) · Acta Neuropathologica · doi:10.1007/s004010050965 · Cited by 34
Graciotti, L., Minelli, A., Minciacchi, D., Procopio, A. D., & Fulgenzi, G. (2008) · Neuromuscular Disorders · doi:10.1016/j.nmd.2007.11.009 · Cited by 33
Humoral Immunity to AAV-6, 8, and 9 in Normal and Dystrophic Dogs
Shin, J., Yue, Y., Smith, B. F., & Duan, D. (2011) · Human Gene Therapy · doi:10.1089/hum.2011.125 · Cited by 32
Self-citationBarbash, I. M., Cecchini, S., Faranesh, A. Z., Virág, T., Li, L., Yang, Y., Hoyt, R. F., Kornegay, J. N., Bogan, J. R., Garcı́a, L., et al. (2012) · Gene Therapy · doi:10.1038/gt.2012.38 · Cited by 32
Hakim, C. H., Yue, Y., Shin, J., Williams, R. R., Zhang, K., Smith, B. F., & Duan, D. (2014) · Molecular Therapy — Methods & Clinical Development · doi:10.1038/mtm.2014.2 · Cited by 31
Self-citationVallese, D., Négroni, E., Duguez, S., Ferry, A., Trollet, C., Aamiri, A., Vosshenrich, C. A. J., Füchtbauer, E., Santo, J. P. D., Vitiello, L., et al. (2013) · Molecular Therapy · doi:10.1038/mt.2013.186 · Cited by 31
Pan, X., Yue, Y., Zhang, K., Lostal, W., Shin, J.-H., & Duan, D. (2013) · Human Gene Therapy · doi:10.1089/hum.2013.044 · Cited by 30 · cited 1×
“More recent studies suggest that AAV-8 and AAV-9 can also produce robust body-wide muscle gene transfer in neonatal dogs (Hakim et al., 2014; Kornegay et al., 2010; Pan et al., 2013; Yue et al., 2008).”
BackgroundSelf-citationUpregulation of brain utrophin does not rescue behavioral alterations in dystrophin-deficient mice
Perronnet, C., Chagneau, C., Leblanc-Veyrac, P., Samson-Desvignes, N., Mornet, D., Laroche, S., de la Porte, S., & Vaillend, C. (2012) · Human Molecular Genetics · doi:10.1093/hmg/dds047 · Cited by 29
Liu, Q., Pérez, C. F., & Wang, Y. (2006) · Journal of Virology · doi:10.1128/jvi.80.4.1672-1679.2006 · Cited by 29
Li, D., Shin, J., & Duan, D. (2011) · PLoS ONE · doi:10.1371/journal.pone.0021618 · Cited by 27
Self-citationNakamura, A., Kobayashi, M., Kuraoka, M., Yuasa, K., Yugeta, N., Okada, T., & Takeda, S. (2013) · Scientific Reports · doi:10.1038/srep02183 · Cited by 27
Duan, D. (2006) · PubMed · Cited by 26
Self-citationCanine X‐linked muscular dystrophy studied with in vivo phosphorus magnetic resonance spectroscopy
McCully, K. K., Giger, U., Vet, M., Argov, Z., Valentine, B. A., Cooper, B. J., & Chance, B. (1991) · Muscle & Nerve · doi:10.1002/mus.880141109 · Cited by 26
Shin, J., Greer, B., Hakim, C. H., Zhou, Z., Chung, Y.-C., Duan, Y., He, Z., & Duan, D. (2013) · PLoS ONE · doi:10.1371/journal.pone.0059875 · Cited by 25
Self-citationYamamoto, K., Yamada, D., Kabuta, T., Takahashi, A., Wada, K., & Sekiguchi, M. (2010) · Neuromuscular Disorders · doi:10.1016/j.nmd.2010.05.006 · Cited by 25
Roles of ADAM8 in elimination of injured muscle fibers prior to skeletal muscle regeneration.
Nishimura, D., Sakai, H., Sato, T., Sato, F., Nishimura, S., Toyama-Sorimachi, N., Bartsch, J., & Sehara-Fujisawa, A. (2015) · Mechanisms of Development · doi:10.1016/j.mod.2014.12.001 · Cited by 25
Deng, Y., Madan, A., Banta, A. B., Friedman, C. L., Trask, B. J., Hood, L., & Li, L. (2000) · Genomics · doi:10.1006/geno.1999.6045 · Cited by 25
Muscular dystrophy in the Japanese Spitz: an inversion disrupts theDMDandRPGRgenes
Atencia-Fernandez, S., Shiel, R. E., Mooney, C. T., & Nolan, C. M. (2015) · Animal Genetics · doi:10.1111/age.12266 · Cited by 24
Truncated dystrophins reduce muscle stiffness in the extensor digitorum longus muscle of mdx mice
Hakim, C. H., & Duan, D. (2012) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00866.2012 · Cited by 24
Self-citationUndetectable dystrophin can still result in a relatively benign phenotype of dystrophinopathy
Hattori, N., Kaido, M., Nishigaki, T., Inui, K., Fujimura, H., Nishimura, T., Naka, T., & Hazama, T. (1999) · Neuromuscular Disorders · doi:10.1016/s0960-8966(99)00005-x · Cited by 24
Emerging gene editing strategies for Duchenne muscular dystrophy targeting stem cells
Bertoni, C. (2014) · Frontiers in Physiology · doi:10.3389/fphys.2014.00148 · Cited by 24
Marshall, J. L., Kwok, Y., McMorran, B. J., Baum, L. G., & Crosbie, R. H. (2013) · FEBS Journal · doi:10.1111/febs.12295 · Cited by 23
Gawlik, K. I., Holmberg, J., & Durbeej, M. (2014) · American Journal Of Pathology · doi:10.1016/j.ajpath.2013.11.017 · Cited by 22
Duan, D. (2008) · PubMed · Cited by 22
Self-citationThe effect of exercise on canine dystrophic muscle
Valentine, B. A., Blue, J. T., & Cooper, B. J. (1989) · Annals of Neurology · doi:10.1002/ana.410260416 · Cited by 20
Aigner, B., Rathkolb, B., Klaften, M., Sedlmeier, R., Klempt, M., Wagner, S., Michel, D., Mayer, U., Klopstock, T., de Angelis, M. H., et al. (2009) · Experimental Physiology · doi:10.1113/expphysiol.2008.045864 · Cited by 20
Ishizaki, M., Maeda, Y., Kawano, R., Suga, T., Uchida, Y., Uchino, K., Yamashita, S., Kimura, E., & Uchino, M. (2011) · Molecular Therapy · doi:10.1038/mt.2011.58 · Cited by 19
Naked plasmid DNA for the treatment of muscular dystrophy.
Braun, S. (2004) · PubMed · Cited by 19
The University of North Carolina at Chapel Hill University Libraries (2020) · Europe PMC (PubMed Central) · doi:10.17615/v6v7-mw24 · Cited by 19
Quantitative changes of nicotinic receptors in the hippocampus of dystrophin-deficient mice
Ghedini, P. C., Avellar, M. C. W., de Lima, T. C. M., Lima‐Landman, M. T. R., Lapa, A. J., & Souccar, C. (2012) · Brain Research · doi:10.1016/j.brainres.2012.09.021 · Cited by 18
Miyazato, L. G., de Moraes, J. R. E., Beretta, D. C., & Kornegay, J. N. (2011) · Veterinary Pathology · doi:10.1177/0300985810387070 · Cited by 16
Altered acetylcholine release in the hippocampus of dystrophin-deficient mice
Parames, S. F., Coletta-Yudice, E. D., Nogueira, F. M., Nering, M. B., Hayashi, M. A. F., Lima‐Landman, M. T. R., Lapa, A. J., & Souccar, C. (2014) · Neuroscience · doi:10.1016/j.neuroscience.2014.03.050 · Cited by 14
Molecular dissection of dystrophin identifies the docking site for nNOS
Harper, S. Q. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1220256110 · Cited by 13
Martins, P. C. M., Ayub-Guerrieri, D., Martins-Bach, A. B., Onofre-Oliveira, P. C. G., Malheiros, J. M., Tannús, A., de Sousa, P. L., Carlier, P. G., & Vainzof, M. (2013) · Disease Models & Mechanisms · doi:10.1242/dmm.011700 · Cited by 13
A New Genetic Variant of MDX Mice: Study of the Phenotype
Krivov, L. I., Stenina, M. A., Yarygin, V. N., Polyakov, A. V., Савчук, В. Й., Obrubov, S. A., & Komarova, N. V. (2009) · Bulletin of Experimental Biology and Medicine · doi:10.1007/s10517-009-0564-5 · Cited by 11
Duchenne Cardiomyopathy Gene Therapy
Shin, J., Bostick, B., Fine, D. M., Yue, Y., & Duan, D. (2009) · Springer eBooks · doi:10.1007/978-1-4419-1207-7_9 · Cited by 10
Self-citationIn vitro characteristics of normal and dystrophic skeletal muscle from dogs
Valentine, B. A., Chandler, S. K., Cummings, J. F., & Cooper, B. J. (1991) · American Journal of Veterinary Research · doi:10.2460/ajvr.1991.52.01.104 · Cited by 10
Duan, D., Hakim, C. H., Ambrósio, C. E., Smith, B. F., & Sweeney, H. L. (2015) · Disease Models & Mechanisms · doi:10.1242/dmm.019216 · Cited by 6
Self-citation
Cited by
Systemic AAV Micro-dystrophin Gene Therapy for Duchenne Muscular Dystrophy
Duan, D. (2018) · Molecular Therapy · doi:10.1016/j.ymthe.2018.07.011 · Cited by 489
Self-citationSkeletal muscle fibrosis: an overview
Mahdy, M. A. A. (2019) · Cell and Tissue Research · doi:10.1007/s00441-018-2955-2 · Cited by 363
Comparative transcriptomics in human and mouse
Breschi, A., Gingeras, T. R., & Guigó, R. (2017) · Nature Reviews Genetics · doi:10.1038/nrg.2017.19 · Cited by 360
GPR41 and GPR43 in Obesity and Inflammation – Protective or Causative?
Ang, Z., & Ding, J. L. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00028 · Cited by 304
The Pathogenesis and Therapy of Muscular Dystrophies
Guiraud, S., Aartsma-Rus, A., Vieira, N. M., Davies, K. E., van Ommen, G.-J. B., & Kunkel, L. M. (2015) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev-genom-090314-025003 · Cited by 302
Metadata
- Authors
- McGreevy, J. W., Hakim, C. H., McIntosh, M. A., & Duan, D.
- Venue
- Disease Models & Mechanisms
- Publisher
- The Company of Biologists
- Published
- 2015-03-01
- Volume
- 8
- Issue
- 3
- Pages
- 195-213
- ISSN
- 1754-8403 (ISSN-L)
- 1754-8411
- OpenAlex
- W2097136884
- Cited by
- 512
- References
- 332
- FWCI
- 17.88
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.